Can the following medications be added to the Non-title XIX SMI formulary?
Any requests for adding generic forms of medications to the DBHS Non-title XIX formulary must be submitted by the RBHA through the established DBHS review process. The Non-title XIX SMI formulary requests will then be reviewed in the DBHS Pharmacy and Therapeutics Committee, and any proposed changes will be discussed with the RBHA Chief Medical Officers. Medications added to the Non-title XIX formulary will apply to all RBHAs.
Related Questions
- Are any biological agents added to the stem cells such as medications or mixtures containing Plasma Enriched Platelets?
- Who makes the decisions regarding the benefit status of medications listed in the Nova Scotia Formulary?
- Is the Risperidal Consta available to any Non-title XIX SMI member presently in treatment?
